Skip to main content
ISTH 2024 Main banner
Back

Kanin Wichapong, PhD

Senior Researcher
Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands
Maastricht, Limburg, Netherlands

Kanin Wichapong studied chemistry and obtained PhD (physical chemistry) from Chulalongkorn University, Bangkok, Thailand. During his PhD study, he also received research grants to carry out parts of his PhD dissertation at the Institute of Pharmacy, Martin-Luther University Halle-Wittenberg, Halle (Saale), Germany. After completion of his PhD, he returned to Germany and worked at Martin-Luther University Halle-Wittenberg as a postdoctoral researcher, and then moved to Maastricht and started his career at the Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM) as a postdoctoral researcher.

Presently, he holds the role of senior researcher at CARIM, specializing in computer-aided molecular design (CAMD) and protein structural bioinformatics. His research interests focus on utilizing computational methods to discover and develop bioactive compounds, such as small-molecule inhibitors, peptides, therapeutic proteins, and PROTACs, for targeting various drug targets. Additionally, he employs various computational approaches to investigate the structures and functions of proteins and to elucidate the interactions between proteins and their binding partners (e.g., proteins, peptides, small compounds, nucleic acids).

Furthermore, he currently serves as the work package leader (WP2: Discovery & Development of Novel Inhibitors for the Identified Drug Targets) and a member of the management board of the PRAETORIAN consortium. (Marie Skłodowska-Curie Actions Doctoral Networks, 2024-2027): PRAETORIAN - EuroPean Training NetwoRks to TArget DAMPs and NETs: novel apprOaches in pRecision SepsIs pAtieNt care (https://www.praetorian-dn.eu/). In addition to his academic career, he is also the co-founder and holds the role of the Chief Technology Officer (CTO) and project manager at Hillmark B.V. (https://www.hillmarkbiopharma.com/).

Presentation(s):